Alexander Eggermont

5 ta ish

Institut Gustave Roussy

1. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

   Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45

   Maqola20175 iqtibos

   ABIABI:AkademIndex/2026.other.339917

2. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

   Marie Vétizou, Jonathan M. Pitt, Romain Daillère +35

   Maqola20154 iqtibos

   ABIABI:AkademIndex/2026.other.339891

3. Dendritic cell–derived exosomes for cancer therapy

   Jonathan M. Pitt, Fabrice André, Sebastián Amigorena +4

   Sharh maqolaOAOchiq kirish20163 iqtibos

   ABIABI:AkademIndex/2026.other.116712

4. Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)

   Célèste Lebbé, Claus Garbe, Alexander J. Stratigos +20

   Maqola20193 iqtibos

   ABIABI:AkademIndex/2026.other.440903

5. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

   Romain Daillère, Marie Vétizou, Nadine Waldschmitt +33

   Maqola20163 iqtibos

   ABIABI:AkademIndex/2026.other.480493